Parallel distribution of original quality products
Parallel trade makes original innovative medicines available at lower costs and provides both direct and indirect savings to social health insurance systems, other third-party payers and consumers.
MPA Pharma acquires majority stake
In April 2012 Germany's MPA Pharma acquired a majority stake in Paranova A/S. For 30 years MPA Pharma and its sales subsidiary EMRAmed have been leading reimporters ...
Low-priced originals!
Paranova buys pharmaceuticals from licensed wholesalers in virtually every country in the EU/EES. To be able to market these products in the country of destination the parallel importer must be provided with a marketing authorization – one license for each product and each country of origin.
